DOS regimen (Docetaxel+Oxaliplatin+S-1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DOS regimen (Docetaxel+Oxaliplatin+S-1), covering 2020-03-02 to 2020-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer [Phase 3]